Sue Latter

4.2k total citations
104 papers, 2.9k citations indexed

About

Sue Latter is a scholar working on General Health Professions, Geriatrics and Gerontology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sue Latter has authored 104 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in General Health Professions, 22 papers in Geriatrics and Gerontology and 22 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sue Latter's work include Pharmaceutical Practices and Patient Outcomes (22 papers), Nursing Roles and Practices (19 papers) and Interprofessional Education and Collaboration (17 papers). Sue Latter is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (22 papers), Nursing Roles and Practices (19 papers) and Interprofessional Education and Collaboration (17 papers). Sue Latter collaborates with scholars based in United Kingdom, Australia and South Africa. Sue Latter's co-authors include Jill Maben, Jill Macleod Clark, Molly Courtenay, Emma Boger, Sara Demain, Alison Blenkinsopp, Alesha Smith, Paul Yerrell, Steven Ersser and Michelle Myall and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Sue Latter

97 papers receiving 2.7k citations

Peers

Countries citing papers authored by Sue Latter

Since Specialization

Citations

This map shows the geographic impact of Sue Latter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Latter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Latter more than expected).

Fields of papers citing papers by Sue Latter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Latter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Latter. The network helps show where Sue Latter may publish in the future.

Co-authorship network of co-authors of Sue Latter

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Latter. A scholar is included among the top collaborators of Sue Latter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Latter. Sue Latter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a complex multidisciplinary medication review and deprescribing intervention in primary care for older people living with frailty and polypharmacy 2025 ·PLoS ONE ·Eloise Radcliffe, Alejandra Recio‐Saucedo, Clare Howard, (unknown), Katherine Bradbury, Paul Rutter, Sue Latter, Mark Lown, (unknown), Simon Fraser, Kinda Ibrahim	4
2	Paramedics providing end-of-life care: an online survey of practice and experiences 2024 ·BMC Palliative Care ·(unknown), Joanne Turnbull, Alison Richardson, Sarah Voss, (unknown), (unknown), Sue Latter	0
3	‘Either something's wrong, or I'm a terrible parent’: A systematic review of parent experiences of illness‐related interpretations for unsettled babies 2024 ·Journal of Advanced Nursing ·(unknown), (unknown), Daniela Ghio, Sue Latter, Miriam Santer, Ingrid Müller	0
4	A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS) 2024 ·International Journal of Clinical Pharmacy ·David Young, Clare Harris, (unknown), (unknown), João Gonçalves, Janet Addison, Justin Harvey, Sue Latter, Fraser Cummings	1
5	P389 Switching infliximab to subcutaneous from intravenous therapy (SWIMSUIT) – A prospective, real-world, single centre, phase IV interventional study. 2023 ·Journal of Crohn s and Colitis ·(unknown), David Young, Helen Moyses, (unknown), Sue Latter, (unknown)	3
6	Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study 2023 ·SHILAP Revista de lepidopterología ·Clare Harris, Richard Harris, David Young, Martin B. McDonnell, (unknown), Justin Harvey, (unknown), (unknown), João Gonçalves, Sue Latter, Fraser Cummings	2
7	P96 Patient benefits of switching from intravenous to subcutaneous infliximab 2023 ·Poster presentations ·(unknown), David Young, Sue Latter, Fraser Cummings	1
8	Patient and carer access to medicines at end of life: the ActMed mixed-methods study 2022 ·SHILAP Revista de lepidopterología ·Sue Latter, (unknown), Jacqueline Birtwistle, Alison Richardson, Mike Bennett, David Meads, Alison Blenkinsopp, Liz Breen, Zoe Edwards, (unknown), (unknown), Sean Ewings, Miriam Santer, Lesley Roberts	4
9	Supporting carers to manage pain medication in cancer patients at the end of life: A feasibility trial 2017 ·Palliative Medicine ·Sue Latter, Jane B. Hopkinson, Elizabeth Lowson, J.A. Hughes, Jacqueline Hughes, (unknown), Sally Anstey, Mike Bennett, Carl May, Peter Smith, Alison Richardson	18
10	How can we help family carers manage pain medicines for patients with advanced cancer? A systematic review of intervention studies 2016 ·BMJ Supportive & Palliative Care ·Sue Latter, Jane B. Hopkinson, Alison Richardson, J.A. Hughes, Elizabeth Lowson, Deborah Edwards	31
11	LPS-mediated effects and spatio-temporal expression of TLR2 and TLR4 in the bovine corpus luteum 2016 ·Reproduction ·J. Lüttgenau, Kathrin Herzog, (unknown), Sue Latter, Alois Boos, (unknown), H. Bollwein, Mariusz P. Kowalewski	21
12	What are the outcomes of self-management that matter to stakeholders? Study protocol for the Self-management VOICED project 2014 ·ePrints Soton (University of Southampton) ·Sara Demain, Emma Boger, Sue Latter, Matthew Hankins, Anne Kennedy, Claire Foster, Fiona Jones, Ian Kellar	5
13	Survey of patients' experiences and perceptions of care provided by nurse and pharmacist independent prescribers in primary care 2013 ·Health Expectations ·Michela Tinelli, Alison Blenkinsopp, Sue Latter, Alesha Smith, Stephen Chapman	37
14	Health experiences of adolescents with uncontrolled severe asthma 2010 ·Archives of Disease in Childhood ·Kay Edgecombe, Sue Latter, Stephen P. Peters, Graham Roberts	46
15	Evidence base for effective medicines management 2010 ·Nursing Standard ·Sue Latter	2
16	Self-management experiences in adults with mild-moderate psoriasis: an exploratory study and implications for improved support 2010 ·British Journal of Dermatology ·Steven Ersser, Fiona Cowdell, Sue Latter, Eugene Healy	43
17	Evaluating nurse independent prescribers' prescribing consultations: An observation study of practice in England 2007 ·South Asian Journal of Cancer ·Sue Latter, Jill Maben, Michelle Myall, Anthony Young, (unknown)	2
18	Evaluating the clinical appropriateness of nurses' prescribing practice: method development and findings from an expert panel analysis 2007 ·BMJ Quality & Safety ·Sue Latter, Jill Maben, Michelle Myall, Amanda Young	21
19	Response 2004 ·Journal of Clinical Nursing ·Molly Courtenay, Sue Latter	1
20	The organization of care: its influence on health education practice on acute wards 1993 ·Journal of Clinical Nursing ·Jill Maben, Sue Latter, Jill Macleod Clark, Jenifer Wilson‐Barnett	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact